Low-Dose Naltrexone for Autoimmune and Chronic Pain Conditions:
A Special Interview With Linda Elsegood and Dr. Sarah Zielsdorf
Low-dose naltrexone, an opiate antagonist, can benefit most autoimmune and chronic pain conditions
LDN is also being used as an adjunct for cancer. Research by professor Angus George Dalgleish and Dr. Wei Lou showed LDN could bring cancer cells into remission using pulsed dosing
When microdosed, LDN can help potentiate long-term users of opioids, allowing them to reduce their dependence and lower their required opioid dose
Naltrexone only briefly blocks the opioid receptor. Its chief clinical benefit is in the rebound effect, which includes an upregulation of your immune system and subsequent reduction in inflammation
Other conditions being treated with LDN include Lyme disease and its co-infections, fibromyalgia, SIBO, restless leg syndrome, depression, dermatological issues and even infertility
Read the full analysis by Dr. Mercola
George W. Bush: The terrorists want to change our lifestyle
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.